Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia

Leukemia

Volumn 27, Issue 5, 2013, Pages 1214-1217

  Schwaederle M ^a   Ghia, E ^a   Rassenti, L Z ^a   Obara, M ^a   Dell'Aquila, M L ^b   Fecteau, J F ^a   Kipps, T J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

B LYMPHOCYTE; CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLONAL EVOLUTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE MUTATION; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SF3B1 GENE; SPLICEOSOME; SURVIVAL; TREATMENT FREE SURVIVAL;

ALLELES; CLONAL EVOLUTION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; PHOSPHOPROTEINS; RIBONUCLEOPROTEIN, U2 SMALL NUCLEAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84877608629     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.22     Document Type: Letter

References (12)

1. Wang LL, Neuberg D, Wu CJ. SF3B1 in chronic lymphocytic leukemia. New Engl J Med 2012; 366: 1057-1058.
2. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New Engl J Med 2011; 365: 1384-1395.
3. Thol F, Kade S, Schlarmann C, Loffeld P, Morgan M, Krauter J et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012; 119: 3578-3584.
4. Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47-U70.
5. Wang LL, Lawrence MS, Wan YZ, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. New Engl J Med 2011; 365: 2497-2506.
6. Quesada V, Ramsay AJ, Lopez-Otin C. Chronic lymphocytic leukemia with SF3B1 mutation. New Engl J Med 2012; 366: 2530-2530.
7. Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904-6908.
8. Mansouri L, Cahill N, Gunnarsson R, Smedby KE, Tjonnfjord E, Hjalgrim H et al. NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia 2012; e-pub ahead of print 6 November 2012; doi:10.1038/leu.2012.307.
9. Visconte V, Makishima H, Jankowska AM, Traina F, Szpurka H, Rogers HJ et al. Association of SF3B1 with ring sideroblasts in patients, in vivo, and in vitro models of spliceosomal dysfunction. Blood 2011; 118: 211-212.
10. Damm F, Thol F, Kosmider O, Kade S, Loffeld P, Dreyfus F et al. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia 2012; 26: 1137-1140.
11. Bejar R, Stevenson K, Caughey B, Abdel-Wahab O, Galili N, Garcia-Manero G et al. Validation of a prognostic model and the impact of SF3B1, DNMT3A, and other mutations in 289 genetically characterized lower risk MDS patient samples. Blood 2011; 118: 443-443.
12. Novak U, Oppliger Leibundgut E, Hager J, Muhlematter D, Jotterand M, Besse C et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL). Blood 2002; 100: 1787-1794.